Bristol-Myers Squibb (BMY)

AI-powered earnings call analysis for Bristol-Myers Squibb. Get insights from quarterly earnings reports with our AI-generated podcast. Educational content only - not investment advice.

10 episodes 5 languages

Next Episode

Bristol-Myers Squibb earnings call scheduled for Jul 30, 2026 (before market open)

New episode expected Jul 31, 2026

Latest Episode

Q1 2026 Earnings

7:45 • 4/30/2026

Bristol-Myers Squibb (BMY) - Q1 2026

0:00

7:45

Speed:

Q1 2026 Earnings

11:35 • 2026/4/30

Bristol-Myers Squibb (BMY) - Q1 2026

0:00

11:35

Speed:

Q1 2026 Earnings

11:00 • 30/04/2026

Bristol-Myers Squibb (BMY) - Q1 2026

0:00

11:00

Speed:

Q1 2026 Earnings

11:48 • 30/4/2026

Bristol-Myers Squibb (BMY) - Q1 2026

0:00

11:48

Speed:

Q1 2026 Earnings

8:14 • 30.4.2026

Bristol-Myers Squibb (BMY) - Q1 2026

0:00

8:14

Speed:

All Episodes

EN - English (2) CN - 中文 (2) FR - Français (2) ES - Español (2) DE - Deutsch (2)

Q1 2026 Earnings

7:45

Bristol-Myers Squibb delivered solid Q1 2026 with $11.5B revenue (+1% YoY) and growth portfolio sales of $6.2B (+9%), driven by Eliquis and cell therapy, while advancing a diversified pipeline with multiple late-stage catalysts expected in late 2026.